[1]
|
Langreth, R. and Waldholz, M. (1999) New era of personalized medicine: targeting drugs for each unique genetic profile. Oncologist, 4, 426-427.
|
[2]
|
President’s Council of Advisors on Science Technology. (2008) Priorities for Personalised Medicine. (www.whitehouse.gov/files/documents/ostp/PCAST/ pcast_report_v2.pdf)
|
[3]
|
Jorgensen, J.T. (2009) New era of personalized medicine: a 10-year anniversary. Oncologist, 14, 557-558.
|
[4]
|
Hamburg, M.A. and Collins, F.S. (2010) The path to personalized medicine. N Engl J Med, 363, 301-304.
|
[5]
|
Biomarkers Definitions Working Group. (2001) Bio-markers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther, 69, 89-95.
|
[6]
|
Hong, H., Goodsaid, F., Shi, L., Tong, W. (2010) Molecular biomarkers: a US FDA effort. Biomarkers Med, 4, 215-225.
|
[7]
|
Lucas, A., Nolan, D., Mallal, S. (2007) HLA-B*5701 screening for susceptibility to abacavir hypersensitivity. J Antimicrob Chemother, 59, 591-593.
|
[8]
|
Mallal, S., Phillips, E., Carosi, G., et al. (2008) HLA-B*5701 screening for susceptibility to abacavir hypersensitivity. N Engl J Med, 358, 568-569.
|
[9]
|
US Food and Drug Administration. Table of valid genomic biomarkers in the context of approved drug labels. Available at: www.fda.gov/Drugs/ScienceResearch /ResearchAreas/Pharmacogenetics/ucm083378.htm.
|
[10]
|
Sanderson, S., Emery, J., Higgins, J. (2005) CYP2C9 gene variants, drug dose, and bleeding risk in warfarin-treated patients: A HuGEnet? systemic review and metaanalysis. Genet Med, 7, 97-104.
|
[11]
|
Takahashi, H., Wilkinson, G.R., Nutescu, E.A., et al. (2006) Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance doses of warfarin in Japanese, Caucasians and African Americans. Pharmacogenet Genomics, 16, 101-110.
|
[12]
|
Kim, M.J., Huang, S.M., Meyer, et al. (2009) A regulatory science perspective on warfarin therapy: A pharacogenetic opportunity. J Clin Pharmacol, 49, 138-146.
|
[13]
|
McGrath, J.P., Capon, D.J., Smith, D.H., et al. (1983) Structure and organization of the human Kiras protooncogene and a related processed pseudogene. Nature, 304, 501-506.
|
[14]
|
Kranenburg, O. (2005) The KRAS oncogene: past, present, and future. Biochim Biophys Acta, 1756, 81-82.
|
[15]
|
Lander, E.S. (1996) The new genomics: Global views of biology. Science, 274, 536-539.
|
[16]
|
The International HapMap Consortium. (2005) A haplo-type map of the human genome. Nature, 437, 1299-1320.
|
[17]
|
The International HapMap Consortium. (2007) A second generation human haplotype map of over 3.1 million SNPs. Nature, 449, 851-862.
|
[18]
|
Klein, R.J., Zeiss, C., Chew, E.Y., et al. (2005) Complement factor H polymorphism in agerelated macular degeneration. Science, 308, 385-389.
|
[19]
|
Dupuis, J., Langenberg, C., Prokopenko, I., et al. (2010) New genetic loci implicated in fasting glucose homeostasis and their impact on TYPE 2 DIABETES risk. Nat Genet, 42, 105-116.
|
[20]
|
Saxena, R., Hivert, M.F. Langenberg, C., et al. (2010) Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet, 42, 142-148.
|
[21]
|
Spars?, T., Bonnefond, A., Andersson, E., et al. (2009) G-allele of intronic rs10830963 in MTNR1B confers increased risk of impaired fasting glycemia and TYPE 2 DIABETES through an impaired glucose-stimulated insulin release: studies involving 19,605 Europeans. Diabetes, 58, 1450-1456.
|
[22]
|
Lavedan, C., Licamele, L., Volpi, S., et al. (2008) Association of the NPAS3 gene and five other loci with response to the antipsychotic iloperidone identified in a whole genome association study. Mol Psychiatry, 14, 804-819.
|
[23]
|
Turner, S.T., Bailey, K.R., Fridley, B.L., et al. (2008) Genomic association analysis suggests chromosome 12 locus influencing antihypertensive response to thiazide diuretic. Hypertension, 52, 359-365.
|
[24]
|
Takeuchi, F., McGinnis, R., Bourgeois, S., et al. (2009) A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose. PLoS Genet, 5, E1000433.
|
[25]
|
Kindmark, A., Jawaid, A., Harbron, C.G., et al. (2008) Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis. Pharmaco-genomics J, 8, 186-195.
|
[26]
|
Daly, A.K., Donaldson, P.T., Bhatnagar, P., et al. (2009) HLA-B*5701 genotype is a major determinant of drug induced liver injury due to flucloxacillin. Nat Genet, 41, 816-9.
|
[27]
|
Zeggini, E., Weedon, M.N., Lindgren, C.M., et al. (2007) Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science, 316, 1336-1341.
|
[28]
|
Scott, L.J., Mohlke, K.L., Bonnycastle, L.L., et al. (2007) A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science, 316, 1341-1345.
|
[29]
|
Sladek, R., Rocheleau, G., Rung, J., et al. (2007) A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature, 445, 881-885.
|
[30]
|
Steinthorsdottir, V., Thorleifsson, G., Reynisdottir, I., et al. (2007) A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet, 39, 770-775.
|
[31]
|
Rung, J., Cauchi, S., Albrechtsen, A., et al. (2009) Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistence and hyperinsulinemia. Nat Genet, 41, 1110-1115.
|
[32]
|
Wellcome Trust Case Control Consortium. (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature, 447, 661-678.
|
[33]
|
Raelson, J.V., Little, R.D., Ruether, A., et al. (2007) Genome-wide association study for Crohn’s disease in the Quebec Founder Population identifies multiple validated disease loci. Proc Natl Acad Sci USA, 104, 14747-14752.
|
[34]
|
Smyth, D.J., Cooper, J.D., Bailey, R., et al. (2006) A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat Genet, 38, 617-619.
|
[35]
|
Gudmundsson, J., Sulem, P., Manolescu, A., et al. (2007) Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet, 39, 631-637.
|
[36]
|
van Heel, D.A., Franke, L., Hunt, K.A., et al. (2007) A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat Genet, 39, 827-829.
|
[37]
|
Tomlinson, I., Webb, E., Carvajal-Carmona, L., et al. (2007) A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat Genet, 39, 984-988.
|
[38]
|
Buch, S., Schafmayer, C., V?lzke, H., et al. (2007) A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease. Nat Genet 2007; 39: 995-999.
|
[39]
|
Winkelmann, J., Schormair, B., Lichtner, P., et al. (2007) Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet, 39, 1000-1006.
|
[40]
|
Zondervan, K.T. and Cardon, L.R. (2007) Designing candidate gene and genome-wide case-control association studies. Nat Protoc, 2, 2492-2501.
|
[41]
|
McCarthy, M.I., Abecasis, G.R., Cardon, L.R., et al. (2008) Genome-wide association studies for complex traits: Consensus, uncertainty and challenges. Nat Rev Genet, 9, 356-369.
|
[42]
|
Pearson, T.A. and Manolio, T.A. (2008) How to interpret a genome-wide association study. JAMA, 299, 1335-1344.
|
[43]
|
Reich, D.E. and Lander, E.S. (2001) On the allelic spectrum of human disease. Trends Genet, 17, 502-510.
|
[44]
|
Barrett, J.C. and Cardon, L.R. (2006) Evaluating coverage of genome-wide association studies. Nat Genet, 38, 659-662.
|
[45]
|
Pe’er, I., Bakker, P.I., Maller, J., et al. (2006) Evaluating and improving power in whole-genome association studies using fixed marker sets. Nat Genet, 38, 663-667.
|
[46]
|
Hong, H., Shi, L., Fuscoe, J.C., et al. (2009) Potential Sources of Spurious Associations and Batch Effects in Genome-Wide Association Studies. In: Batch Effects and Noise in Microarray Experiments: Sources and Solutions, edited by A. Scherer, John Wiley & Sons, West Sussex, United Kingdom, p191-201.
|
[47]
|
Hong, H., Shi, L., Su, Z., et al. (2010) Assessing sources of inconsistencies in genotypes and their effects on genome-wide association studies with HapMap samples. The Pharmacogenomics Journal, 10, 364-374.
|
[48]
|
Takeuchi, F., Serizawa, M., Yamamoto, K. et al. (2009) Confirmation of multiple risk Loci and genetic impacts by a genome-wide association study of TYPE 2 DIA-BETES in the Japanese population. Diabetes, 58, 1690-1699.
|
[49]
|
Saxena, R., Voight, B.F., Lyssenko, V., et al. (2007) Genome-wide association analysis identifies loci for TYPE 2 DIABETES and triglyceride levels. Science, 316, 1331-1336.
|
[50]
|
Di, X., Matsuzaki, H., Webster, T.A., et al. (2005) Dynamic model based algorithms for screening and geno-typing over 100K SNPs on oligonucleotide microarrays. Bioinformtics, 21, 1958-1963.
|
[51]
|
Hong, H., Su, Z., Ge, W., et al. (2010) Evaluating Variations of Genotype Calling: A Potential Source of Spurious Associations in Genome-Wide Association Studies. Journal of Genetics, 89, 55-64.
|
[52]
|
Hong, H., Su, Z., Ge, W., et al. (2008) Assessing batch effects of genotype calling algorithm BRLMM for the Affymetrix GeneChip Human Mapping 500K Array Set using 270 HapMap samples. BMC Bioinformatics, 9, S17.
|
[53]
|
Margulies, M., Egholm, M., Altman, W.E., et al. (2005) Genome sequencing in microfabricated high-density picolitre reactors. Nature, 437, 376-380.
|
[54]
|
Fullwood, M.J., Wei, C.L., Liu, E.T. and Ruan, Y. (2009) Next-generation DNA sequencing of paired-end tags (PET) for transcriptome and genome analyses. Genome Res, 19, 521-532.
|
[55]
|
Bansal, V., Harismendy, O., Tewhey, R., et al. (2010) Accurate detection and genotyping of SNPs utilizing population sequencing data. Genome Res, 20, 537-545.
|
[56]
|
Nielsen, R., Paul, J.S., Albrechtsen, A. and Song, Y.S. (2011) Genotype and SNP calling from next-generation sequencing data. Nat Rev Genet, 12, 443-451.
|
[57]
|
Bus, A., Hecht, J., Huettel, B., Reinhardt, R. and Stich, B. (2012) High-throughput polymorphism detection and genotyping in Brassica napus using next-generation RAD sequencing. BMC Genomics, 13, 281.
|
[58]
|
Skotte, L., Korneliussen, T.S. and Albrechtsen, A. (2012) Association testing for next-generation sequencing data using score statistics. Genet Epidemiol, 36, 430-437.
|